NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/14/2025
Back to search
Official data from USPTO
MSIGHT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
11/15/2025
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
02/14/2022
Registration date
08/15/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/15/2023
Last transaction
11/15/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
33
Owner location
FR
Examiner
LIEBL, ALEXANDRA
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "MSIGHT" where a blood drop appears within the initial "M".
Holders and representatives
Holders
SEBIA
Representatives
Thomas J. Mango Cantor Colburn LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Development of new technology for others in the field of biotechnology; medical and scientific research in the field of cancer treatment and diagnosis; providing information in medical and scientific research in the field of clinical trials; providing medical and scientific research information in the pharmaceutical field; research and development in the field of pharmaceuticals and biotechnology; providing diagnostic services in the field of multiple myeloma for residual diseases and analysisevaluation and reporting of the results of such tests to help healthcare professionals determine the clinical diagnosis of a patientevaluate the effectiveness of treatments prescribed to patients and change future treatments accordingly; scientific and technological servicesresearch and design in the field of cancer monitoring; industrial analysis and research in the field of cancer monitoring; design and development of computer software
Publications
History of USPTO decisions and trademark events.
26 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/11/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/16/2023
FIMP
FINAL DISPOSITION PROCESSED
11/15/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/15/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/15/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/15/2023
GPNX
NOTIFICATION PROCESSED BY IB
05/30/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/30/2023
PUBO
PUBLISHED FOR OPPOSITION
05/30/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/10/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/25/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/24/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/24/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/24/2023
RFNT
REFUSAL PROCESSED BY IB
02/21/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/30/2023
RFRR
REFUSAL PROCESSED BY MPU
01/30/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/02/2022
CNRT
NON-FINAL ACTION WRITTEN
12/01/2022
DOCK
ASSIGNED TO EXAMINER
11/29/2022
MAFR
APPLICATION FILING RECEIPT MAILED
04/19/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/15/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/14/2022
Continuous trademark protection
Get notified about every new filing that threatens MSIGHT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.